Globally, drug-resistant bacterial infections killed over 1.2 million people and played a role in 4.95 million deaths in 2019. By 2050, superbugs are expected to kill more than 10 million people each year, outpacing annual deaths from cancer.
Globally, drug-resistant bacterial infections killed over 1.2 million people and played a role in 4.95 million deaths in 2019. By 2050, superbugs are expected to kill more than 10 million people each year, outpacing annual deaths from cancer.
Addressing antimicrobial resistance is not just a global health imperative, but an economic necessity. Without action to curb superbugs, their…
Read MoreNovember 18-24, 2024 marks the 10th annual World AMR Awareness Week (WAAW). This global campaign aims to raise awareness about…
Read MoreIn the last decade, the FDA has approved several new antibiotics from small companies. Today, nearly every company behind those…
Read MoreThe PASTEUR Act establishes a subscription-style model for the U.S. government to secure a reliable supply of novel antimicrobials to address the…
Read More